• Citer

Histology as a potential clinical predictor of outcome in advanced non-small-cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy.

par Wibmer, Thomas;Berghmans, Thierry ;Kropf-Sanchen, Cornelia;Lafitte, Jean-Jacques;Rüdiger, Stefan;Paesmans, Marianne ;Blanta, I;Scherpereel, Arnaud;Stoiber, Kathrin M;Rottbauer, Wolfgang;Sculier, Jean-Paul ;Schumann, Christian
Référence Lung, 191, 3, page (271-280)
Publication Publié, 2013-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	Histology as a potential clinical predictor of outcome in advanced non-small-cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy.
Auteur:	Wibmer, Thomas; Berghmans, Thierry; Kropf-Sanchen, Cornelia; Lafitte, Jean-Jacques; Rüdiger, Stefan; Paesmans, Marianne; Blanta, I; Scherpereel, Arnaud; Stoiber, Kathrin M; Rottbauer, Wolfgang; Sculier, Jean-Paul; Schumann, Christian
Informations sur la publication:	Lung, 191, 3, page (271-280)
Statut de publication:	Publié, 2013-06
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Clinical markers
	Histology
	Mitomycin
	Non-small-cell lung cancer
	Personalized medicine
	Vinorelbine
Note générale:	Journal Article
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0341-2040
	info:doi/10.1007/s00408-013-9458-4
	info:scp/84878684383
	info:pmid/23564228